CD274 and cancer: Moreover, HIV infection has already been proved to be responsible for the upregulation of PD-1 in CD8 cells [67], so the use in HIV positive cancer patients of checkpoint inhibitors affecting the PD-1/PD-L1 axes is a double-edged weapon targeting the infectious disease and cancer.